fbpx

Untreatable Gonorrhea – The Next Infectious Threat

[additional-authors]
February 24, 2012

Our old nemesis, the clap, is in the news again this month.

Gonorrhea is the second most common sexually transmitted disease in the US, with more than 600,000 cases annually. In men it usually causes pain on urination, penile discharge, or sore throat. In women it may not cause symptoms or may cause painful urination, vaginal discharge, or sore throat. If untreated, gonorrhea can spread to the fallopian tubes, joints, and heart valves. I know that most readers simply can’t hear enough about penile discharge (especially if they’re reading this over lunch), I’ve included a microscopic image of exactly that. The gonorrhea bacteria are visible as the small dark dots.

With the discovery of penicillin in the 1940s the treatment of gonorrhea was revolutionized. But ever since that major victory gonorrhea has won several important battles. Gonorrhea developed resistance to sulfanilamide in the 1940s and to penicillins and tetracyclines in the 1980s. When I trained in internal medicine in the mid 1990s, Cipro (an antibiotic in the family called fluoroquinolones) was the preferred treatment for gonorrhea. In the 2000s some fluoroquinolone-resistant strains of gonorrhea appeared and by 2007 resistance was widespread.

Third generation cephalosporins are now the last antibiotic family to which gonorrhea is susceptible. But, as a decade ago with fluoroquinolones, sensitivity to cephalosporins is slowly decreasing, especially in the western US. Though no strain in the US has become resistant yet, a strain isolated from a patient in Japan in 2009 was highly resistant to cephalosporins.

The downward creeping cephalosporin sensitivity of gonorrhea prompted CDC researchers to sound the alarm in an ” target=”_blank”>corny public health posters encouraging men to keep their flies zipped.

Learn more:

” target=”_blank”>Gonorrhea Could Join Growing List of Untreatable Diseases (Scientific American)
” target=”_blank”>The Emerging Threat of Untreatable Gonococcal Infection (New England Journal of Medicine)

Did you enjoy this article?
You'll love our roundtable.

Editor's Picks

Latest Articles

When ‘Peace’ Breaks Out

Ultimately, although he presented himself as a disruptor, Trump remains captive to the conceptual frameworks, values and norms of Western societies, which place them at a disadvantage in the current clash of civilizations.

We Need a Long-Term Strategy to Deal with Iran

In handing Tehran the keys to lock up the region without a fight, Trump would become the first American president to sign away his country’s right to ply international waters freely.

Hope Is Not a Foreign Policy

The “deal,” as far as is known right now, is simply a 60-day extension of the ceasefire. The can will be kicked down the road.

A Heavenly Service

During these days when it is so easy to succumb to despair, religious services can serve as a wonderful antidote to hopelessness. Especially this one.

What My Soul Knows Before I Do

Sometimes the soul arrives before the explanation does. And sometimes, just before dawn, the world becomes quiet enough for us to notice the first light.

Jewish Caucus Stands Up

One of the best-kept secrets in California politics is the effectiveness and growing influence of the Legislative Jewish Caucus.

Did Trump and Bibi Lose to a Strait Flush?

There’s no bigger sign of failure than to consider a return to the status quo at Hormuz a “great deal.” Never mind that Iran will no doubt use the Strait as leverage in the future.

Regime Change, Interrupted

Signing an agreement with the remnants of this crumbling regime is tantamount to no agreement at all. This cast of sorry diplomats is duplicity incarnate.

An Israeli Leftist Gets Mugged by Reality

These Palestinian filmmakers didn’t need any excuse to crush an artist. All they needed to know was that Lapid was Israeli. Never mind that he supports boycotting the country they hate.

More news and opinions than at a Shabbat dinner, right in your inbox.